The Research, Scholarship, and Artistic Achievement Awards nomination deadline has been extended to May 31, 2024. Click here for more information.

Method for Assessing Diabetes Management and Assessing Risk for Diabetes-related Complications


Tulane University is actively seeking commercial entities to further develop and commercialize our novel test for diagnosing and monitoring diabetes


The invention provides a novel method for detecting and quantifying levels of A1c in the blood. The invention also provides methods of using the results to diagnose and monitor the progression of diabetes. Can be used to detect various A1c fractions. Can be used with various rapid immunoassay systems, including ELISAs. Can be used to detect and monitor other chronic conditions, such as glucose-mediated chronic vascular disease, Alzheimer’s, and sickle cell.

Current Work

This technology has been tested in a laboratory setting.

Intellectual Property

US Provisional Patent Application 61/923,799

Available For

Non-exclusive License
Scientific Collaboration

For more information, please contact: